News from advanceCOR

Company news and press reports: Here you can find out how we inform the public and what the media is writing about us.

Our press releases


May 2020 – Further financing round with a consortium of investors completed. – Read text as PDF

February 2020 – Milestone in novel therapy of M. Basedow reached. – Read text as PDF

January 2020 – Phase II study with Revacept for stroke successfully completed. – Read text as PDF


May 2019 – advanceCOR secures rights to anti-GPVI antibodies from Morphosys – Read text as PDF


December 2018 – Patient recruitment for Phase II study with Revacept completed. – Read text as PDF


May 2016 – BMBF supports advanceCOR projects in the programme “Individualised Medicine”. – Read text as PDF


August 2015 – Second financing round closed. MIG AG as main investor. – Read text as PDF


April 2013 – Phase II study with Revacept in acute stroke/TIA initiated. – Read text as PDF

March 2013 – First financing round closed. Main investor: MIG AG. – Read text as PDF

Media reports about us


June, 16, 2020 – “advanceCOR closes another financing round of EUR 3.9 million”, in: – The capital markets portal – Read text online

June, 3, 2020: “Thrombosis: Fresh money for therapy option”, in: transcript – economy technology life – Read text online


2018 – “With fresh money into the heartbeat final”, in: transcript – Economy Technology Life, Issue 7-8/2018 – Read text online